Singapore: Novartis has recieved USFDA approval for Promacta (eltrombopag) for the treatment of children six years and o...
Singapore: Agilent Technologies plans to collaborate with the University of Queensland Center for Clinical Research in B...
Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercializati...
Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers...
Singapore: AMRI has acquired all the outstanding shares of Spanish firm, Gadea Pharmaceutical Group, specializing in tec...
Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug pere...
Singapore: SCIEX, a life science analytical technologies provider, and Metabolon, a global company focused on metabolomi...
Singapore:Â RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus...
Singapore: European Medicines Agency (EMA) has given a positive indication to Novartis' combination therapy of Tafinlar ...
Singapore: Dr Irwin Rose, an American biologist, who shared Nobel Prize in Chemistry in 2004 for the discovery of cell b...
Singapore: Novartis' phase III psoriasis study of secukinumab (AIN457) has showed positive outcome in clearing skin to E...
Singapore: China based diagnostic company, Shuwen Biotech, and pharmaceutical firm, Jiangsu Hengrui Medicine have partne...
Singapore: Bayer HealthCare and its development partner Janssen Pharmaceuticals have initiated the CALLISTO Clinical Res...
Singapore: ASLAN Pharmaceuticals has inked a memorandum of understanding with Singapore's National Cancer Center (NCCS) ...
Singapore: While the treatment pipeline for pancreatic cancer shows a high level of innovation, with 52 percent of produ...
Singapore: US Food and Drug Administration has approved Varubi (rolapitant), marketed by US based, to prevent delayed ph...
Singapore: Bristol-Myers Squibb has elected Dr Thomas J Lynch to the board, effective January 1, 2014. Dr Lynch will ser...
Physicians at 23 brain cancer centers in Japan are now certified to provide Optune to recurrent glioblastoma patients on...
